OpenVSafe by OpenVAERS
Search V-safe

Q5E-26859-06380

3 vaccinations 5 coded responses 10 check-ins 4 free-text entries 0 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
208 / MD
Registered
2022-06-28
Relationship
Child or adolescent in my care
Guardian
GTF-22093-31119
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-27
    Dose 1 — Pfizer-BioNTech
  2. 2022-06-28
    Registered in v-safe
  3. 2022-07-11
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  4. 2022-07-18
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  5. 2022-07-25
    Survey response — day 28, dose 1, under 3
    MedDRA: Malaise — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Covid symptoms
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-08-01
    Health check-in — day 35, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  7. 2022-08-08
    Health check-in — day 42, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  8. 2022-08-12
    Dose 2 — Pfizer-BioNTech
  9. 2022-09-26
    Survey response — 3 months, dose 1, under 3
    MedDRA: Respiratory tract congestion — Feeling: Good
    Free text: Congestion
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-10-12
    Dose 3 — Pfizer-BioNTech
  11. 2022-10-18
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school
    Free text: Congestion and runny nose
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-10-19
    Survey response — day 7, dose 3, under 3
    MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Sleepiness
    Free text: Runny nose/ congestion
    MedDRA releases: 2024-11 · check-in free text available
  13. 2023-01-11
    Health check-in — 3 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  14. 2023-04-14
    Survey response — 6 months, dose 3, under 3
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-06-27Pfizer-BioNTech No
22022-08-12Pfizer-BioNTech No
32022-10-12Pfizer-BioNTech No

Free text

Release 12 (Under 3) — day 28, dose 1, under 3

2022-07-25

Symptoms: Covid symptoms

Release 12 (Under 3) — 3 months, dose 1, under 3

2022-09-26

Symptoms: Congestion

Release 12 (Under 3) — days 1–6 daily, dose 3, under 3

2022-10-18

Systemic reaction (other): Congestion and runny nose

Release 12 (Under 3) — day 7, dose 3, under 3

2022-10-19

Systemic reaction (other): Runny nose/ congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDMalaise · · ✓
SDNasopharyngitis · · ✓
SDRespiratory tract congestion · · ✓
SRORespiratory tract congestion · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…